Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
Maciej Juryńczyk(John Radcliffe Hospital), Jacqueline Palace(Mayo Clinic), Ingo Kleiter(Dentsply Sirona (United States)), Damian Wren(Atkins (United Kingdom)), de Sèze(Université de Strasbourg), Sandra Vukusic(Institut NeuroMyoGène), Nasrin Asgari(University of Southern Denmark), Krzysztof Selmaj(University of Warmia and Mazury in Olsztyn), Ruth Geraldes(University of Lisbon), Brian G. Weinshenker(Mayo Clinic in Arizona), Lekha Pandit(Humboldt-Universität zu Berlin), Zsolt Illés(Universität Hamburg), Aksel Sıva(Istanbul University), Friedemann Paul(Max Delbrück Center), Marie D’hooghe, Ichiro Nakashima(Tohoku University), Radu Tănăsescu(University of Nottingham), Abhijit Chaudhuri(Queen's Hospital), Sean J. Pittock(Mayo Clinic), Romain Marignier(Hospices Civils de Lyon), Michael Levy(Centre Hospitalier Universitaire de Martinique), Ho Jin Kim(National Cancer Center), David Barnes(Atkins (United Kingdom)), Christopher McGuigan(Cardiff University), Anu Jacob(Abu Dhabi University), Mike Boggild(University of Liverpool), Gülşen Akman‐Demir(Istanbul Bilim University), Katy Murray(MRC Centre for Regenerative Medicine), Nikos Evangelou(Brigham and Women's Hospital), Isabel Leite(John Radcliffe Hospital), Dean M. Wingerchuk(WinnMed)
Cited by 65
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k